Health Care/Hospital

Southstar Drug Gets Ready for the Future with Huawei Wi-Fi 6

MANILLA, Philippines, Jan. 7, 2020 /PRNewswire/ -- Recently, by choosing a wireless Wi-Fi-6 network from Huawei, Southstar Drug is able to operate its business more efficiently and at greater speed, with better access to resources,helping to boost employee productivity. Southstar Drug, a subsidi...

2020-01-08 00:01 1343

Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies

SUZHOU, China and SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced the initiation of an investigational study of GC027, the first product candidate developed usingTruUCAR™ to treat relapsed or refr...

2020-01-07 22:00 1067

Beta Lifescience Announces the Online Availability of Quality Immune Checkpoint Proteins for Scientific Discoveries

FIREFILED, N.J., Jan. 7, 2020 /PRNewswire/ -- Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the...

2020-01-07 21:10 850

LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology

LumaCyte's Radiance platform has broad capabilities aiding in real-time label-free characterization of single-cells giving rise to better understanding of cellular systems and improving process optimization SANTA CLARA, California, Jan. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the...

2020-01-07 20:07 869

Continued Success of Novoheart to Receive R&D Grants: Innovation Technology Fund for Developing Smart Cardiac Screening Technologies

* Grant will fund advanced R&D and incorporation of artificial intelligence (AI) technology to accelerate drug development using Novoheart's bio-engineered human heart chambers and tissues * Potential advancements expected to increase scale and capabilities of Novoheart's MyHeart™ Platform an...

2020-01-07 17:39 2823

Mundipharma Announces Exclusive Deal for Biosolution's CartiLife(R) in South Korea

SINGAPORE, Jan. 7, 2020 /PRNewswire/ -- Mundipharma has announced today that it has sealed an exclusive sales agreement with Biosolution Co., Ltd, a Korea-based leader in cell-based biotechnology, to market and distribute its fourth-generation autologous chondrocyte implantation product, CartiLif...

2020-01-07 11:37 3159

SIT Offers Singapore's First Undergraduate Degrees in Speech and Language Therapy and Digital Communications and Integrated Media in AY2020

SINGAPORE, Jan. 7, 2020 /PRNewswire/ -- In line with the university's mission to offer applied degree programmes targeted at growth sectors of the economy, the Singapore Institute of Technology (SIT) will launch two new degree programmes in Academic Year 2020/2021 - Bachelor of Science with Honou...

2020-01-07 11:00 1309

genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models

genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system LYON, France, Jan. 7, 2020 /PRNewswire/ -- genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic ...

2020-01-07 09:00 3083

InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab

SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd., a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, today announced that the company has entered into a clinical collaboration with a subsidiary of Merck & C...

2020-01-07 08:25 3569

Japanese Clinical Study of DiscGenics' Cell Therapy for Disc Degeneration Passes Initial Safety Review

SALT LAKE CITY and TOKYO, Jan. 7, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that IDCT has p...

2020-01-07 08:00 1462

Transcenta to Present at the 38th Annual J.P. Morgan Healthcare Conference

HONG KONG, SUZHOU, China and HANGZHOU, China, Jan. 6, 2020 /PRNewswire/ -- Transcenta Holding (Transcenta) today announced that Co-founder & CEO Dr. Xueming Qian will present at the 38th Annual J.P. Morgan Healthcare Conference onWednesday, January 15, 2020, at 14:30 PST in Golden Gate room at Wes...

2020-01-07 00:00 1320

Presagen and Life Whisperer Announce Call-out for a Global IVF Clinic Collaboration at CES 2020

SAN MATEO, Calif. and ADELAIDE, Australia, Jan. 6, 2020 /PRNewswire/ -- Life Whisperer, the fertility arm of AI healthcare company Presagen, which operates out ofSan Mateo and South Australia, recently presented the results of groundbreaking research at the prestigious American Society for Reprod...

2020-01-06 23:47 1444

Inovio Provides Update on Clinical Program Plans for 2020

Inovio to present 2020 program plans at Biotech Showcase 2020 Conference PLYMOUTH MEETING, Pennsylvania, Jan. 6, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that Inovio's President & CEO, Dr. J. Joseph Kim will present a corporate update of the company's clinical progr...

2020-01-06 21:00 3041

Happiness Biotech Announces the Opening of its First Experience Store in Hainan, China, introducing the Company's 31st Experience Store

NANPING, China, Jan. 6, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today the opening of its first experience store inHainan, China, which is the Company's 31st experience ...

2020-01-06 21:00 9477

12th Consecutive Year Leading United States in Organ Donation for Gift of Life Donor Program

PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ -- For the 12th consecutive year, Gift of Life Donor Program is the nation's leading organ procurement organization (OPO), coordinating the most life-saving organs for transplant among all 58 U.S. OPOs.

2020-01-06 20:00 2902

BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Not intended for US-, Canada- and UK-based media  - At the planned interim analysis, Phase III JAVELIN Bladder 100 study met the primary endpoint of prolonging overall survival (OS) as a first-line maintenance treatment versus standard of care - BAVENCIO is the first immunotherapy to signifi...

2020-01-06 20:00 4792

Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer

SHANGHAI and PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ -- Antengene Corporation today announced its appointment of Mr.John Chin, MBA, as Chief Business Officer (CBO). He will be responsible for the company's global business development and commercialization, and will report directly to Dr.Jay Mei, ...

2020-01-06 20:00 3716

Lianluo Smart Announces Receipt of Nasdaq Non-compliance of Stockholders' Equity Notification

BEIJING, Jan. 6, 2020 /PRNewswire/ -- Lianluo Smart Limited (the "Company") announced today that it has received a letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") onJanuary 2, 2020, providing notification that the Company no longer complies with the minimum of$2.5 mi...

2020-01-06 19:00 9913

Dr. Nalini Rajamannan Comments on FDA Congressional Letter to Senate Finance Committee After Kaiser Health News Reveals Access to Exempt FDA Database

SHEBOYGAN, Wis., Jan. 6, 2020 /PRNewswire/ -- Dr. Nalini Rajamannan -- a specialist for patients with valvular heart disease in Most Sacred Heart of Jesus Cardiology,Sheboygan, WI -- confirms today that patients finally may get answers about whether medical devices placed in their bodies are test...

2020-01-06 19:00 1370

CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs

SHANGHAI, Jan 6, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced appointment ofYong Fan, MD, as Senior Vice President, Global Regulatory Affairs. Dr. Fan, will be responsible for CAR...

2020-01-06 18:00 4022